Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

Immune therapy is a promising field within oncology but has been unsuccessful in ovarian cancer (OC). Still, there is rationale and evidence supporting immune therapy in OC. We investigated the potential for adoptive cell therapy (ACT) from in vitro expanded tumor-infiltrating lymphocytes (TILs) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kverneland, Anders Handrup, Pedersen, Magnus, Westergaard, Marie Christine Wulff, Nielsen, Morten, Borch, Troels Holz, Olsen, Lars Rønn, Aasbjerg, Gitte, Santegoets, Saskia J., van der Burg, Sjoerd H., Milne, Katy, Nelson, Brad H., Met, Özcan, Donia, Marco, Svane, Inge Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275789/
https://www.ncbi.nlm.nih.gov/pubmed/32547707
http://dx.doi.org/10.18632/oncotarget.27604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275789/
https://www.ncbi.nlm.nih.gov/pubmed/32547707
http://dx.doi.org/10.18632/oncotarget.27604

Ejemplares similares